After conducting transduction, VITEK 2 was used for AST to compare the wild-type recipient and transductant. Looking at the results, the original wild-type recipient exhibited a higher MIC for ampicillin compared to the transductant. Could the transductant's reduced resistance to the antibiotic suggest that the bacteriophage modified its resistance gene?